- Home
- » Tags
- » Variant of concern
Top View
- SARS-Cov-2 Variants of Concern, Gamma (P.1) and Delta
- Coronavirus: Quello Che C'è Da Sapere – 19 Luglio 2021
- COVID-19 Weekly Epidemiological Update 25 February 2021
- Neutralizing Activity of BBIBP-Corv Vaccine-Elicited Sera Against Multiple SARS-Cov-2 Variants of Concern
- COVID-19: Unmasking Emerging SARS-Cov-2 Variants, Vaccines and Therapeutic Strategies
- U.S. Senate Committee on Health, Education, Labor & Pensions
- COVID Updates May 13 – 19, 2021
- Progress of the COVID-19 Vaccine Effort: Viruses, Vaccines
- COVID 19 Risk Related to Spread of New SARS Cov 2 Variants EU EEA
- SYNTHESIS 05/26/2021 COVID-19 B.1.617 Variant of Concern – What We Know So Far
- An Appraisal of the Current Scenario in Vaccine Research for COVID-19
- Will Mutations in the Spike Protein of SARS-Cov-2 Lead to the Failure Of
- IDMA Bulletin 21St June 2021
- COVID-19 Weekly Epidemiological Update
- Evolving Patterns in COVID-19: the Virus, Its Variants and Infectivity-Cum-Virulence
- COVID-19 Variants Identified in Montana Updated 7/20/2021
- CDC/IDSA COVID-19 Clinician Call the Global COVID-19 Situation: Focus on India May 8, 2021 Q&A Plus Additional Resources
- COVID-19 Weekly Epidemiological Update
- Comparing SARS-Cov-2 Variants of Concern (Vocs)* As of May 31, 2021
- Structural Evaluation of the Spike Glycoprotein Variants on SARS-Cov-2 Transmission and Immune Evasion
- Focus on COVID-19 Vaccines: Mrna Vaccines Key Messages: COVID-19 Mrna Vaccines
- COVID-19 Weekly Epidemiological Update
- COVID-19 Vaccine Doses for Countries in Latin America and the Caribbean
- What Is the Efficacy and Effectiveness of Available COVID-19 Vaccines In
- Guidance for Surveillance of SARS-Cov-2 Variants
- Case Study of Two Post Vaccination SARS-Cov-2 Infections with P1 Variants in Coronavac Vaccinees in Brazil
- Understanding the Covid-19 Variants of Concern
- SARS-Cov-2 Sequencing and Variants in Washington State Washington State Department of Health September 22, 2021
- Vaccine Effectiveness Against Referral to Hospital and Severe Lung Injury Associated with COVID19: a PopulationBased CaseControl Study in St
- Risk Related to the Spread of New SARS-Cov-2 Variants of Concern
- Infectivity and Immune Escape of the New SARS-Cov-2 Variant of Interest Lambda
- COVID-19 Weekly Epidemiological Update
- Effectiveness of the Coronavac Vaccine in Older Adults During a BMJ: First Published As 10.1136/Bmj.N2015 on 20 August 2021
- Neutralization of SARS-Cov-2 VOC 501Y.V2 by Human Antisera Elicited by Both
- FACT SHEET COVID-19 Disease (SARS-Cov-2 Virus)
- Delta Variant of SARS-Cov-2 in Arkansas July 2, 2021
- Briefing: Vaccines and Variants
- COVID-19 Variants Identified in Montana Updated 8/11/2021
- Update on Emerging SARS-Cov-2 Variants and COVID-19 Vaccines
- Update on Emerging SARS-Cov-2 Variants and Vaccine Considerations
- Preclinical Evaluation of a SARS-Cov-2 Mrna Vaccine PTX-COVID19-B
- Public Health England Was Created on 5 March 2021
- Vaccine Development Against COVID-19: Study from Pre-Clinical Phases to Clinical Trials and Global Use
- COVID-19 B.1.1.7 (501Y.V1) Variant of Concern – What We Know So Far
- COVID-19 Weekly Epidemiological Update
- VACCINES Scientific Update on COVID-19
- Master Question List for COVID-19 (Caused by SARS-Cov-2) Weekly Report 02 February 2021
- COVID Lit Review Week 30&31 2021.Xlsx
- What Is the Efficacy and Effectiveness of Available COVID-19 Vaccines In
- A Summary of the SARS-Cov-2 Vaccines and Technologies Available Or Under Development
- Ra Capital's Covid-19 Map
- SARS-Cov-2 Variants of Concern and Variants Under Investigation in England
- Vaccines - Viral Variants
- SARS-Cov-2 Virus Mutations & Variants